Inventor · disambiguated record
Kevin Hestir
Also filed as: HESTIR KEVIN · QIN MINMIN
17 granted patents·17 pending applications·125 citations·filing 2004–2022
93Inventor score
Top patents by PatentIndex Score
34 records- 0195US9765147B2Anti-CSFR1 antibody and anti PD-1 antibody combination therapy for cancerFIVE PRIME THERAPEUTICS INC·Filed 2015·Granted Sep 19, 2017·25 cites·31 claims
- 0295US7982014B2FGFR3-IIIc fusion proteinsFIVE PRIME THERAPEUTICS INC·Filed 2010·Granted Jul 19, 2011·24 cites·12 claims
- 0394US8580936B2Polynucleotides encoding FGFR1-IIIc ECD fusion proteinsWILLIAMS LEWIS T·Filed 2011·Granted Nov 12, 2013·40 cites·25 claims
- 0492US10221244B2Anti-CSF1R antibody and anti PD-1 antibody combination therapy for cancerFIVE PRIME THERAPEUTICS INC·Filed 2017·Granted Mar 5, 2019·10 cites·31 claims
- 0589US7776564B2Stromal cell-derived factor-1 polypeptides, polynucleotides, modulators thereof and methods of useFIVE PRIME THERAPEUTICS INC·Filed 2005·Granted Aug 17, 2010·15 cites·13 claims
- 0688US10618967B2Anti-CSF1R antibody and anti PD-1 antibody combination therapy for cancerFIVE PRIME THERAPEUTICS INC·Filed 2019·Granted Apr 14, 2020·5 cites·31 claims
- 0781US2023212299A1Anti-CSF1R Antibody and Anti-PD-1 Antibody Combination Therapy for CancerFIVE PRIME THERAPEUTICS INC·Filed 2022·Application pending·0 cites
- 0880US8324165B2Compositions for treating arthritis comprising HG1023575 polypeptidePENTA KALYANI·Filed 2009·Granted Dec 4, 2012·4 cites·3 claims
- 0973US2009286954A1Human cDNA Clones Comprising Polynucleotides Encoding Polypeptides and Methods of Their UseFIVE PRIME THERAPEUTICS INC·Filed 2009·Application pending·0 cites
- 1072US8575312B2Compositions and methods of use for MGD-CSF in disease treatmentBEHRENS DIRK·Filed 2012·Granted Nov 5, 2013·2 cites·11 claims
- 1171US11566076B2Anti-CSF1R antibody and anti-PD-1 antibody combination therapy for selected cancersFIVE PRIME THERAPEUTICS INC·Filed 2020·Granted Jan 31, 2023·0 cites·25 claims
- 1270US2008182974A1Human cDNA clones comprising polynucleotides encoding polypeptides and methods of their useFIVE PRIME THERAPEUTICS INC·Filed 2007·Application pending·0 cites
- 1366US9192683B2Methods of treating disease with FGFR1 fusion proteinsFIVE PRIME THERAPEUTICS INC·Filed 2013·Granted Nov 24, 2015·0 cites·21 claims
- 1465US9173957B2FGFR2 fusion proteins comprising C-terminal deletion mutants of FGFR2-IIICFIVE PRIME THERAPEUTICS INC·Filed 2013·Granted Nov 3, 2015·0 cites·6 claims
- 1565US2023192870A1Combination Anti-CSF1R and Anti-PD-1 Antibody Combination Therapy for Pancreatic CancerFIVE PRIME THERAPEUTICS INC·Filed 2022·Application pending·0 cites
- 1664US2017349643A1Compositions and methods of treating disease with fgfr fusion proteinsFIVE PRIME THERAPEUTICS INC·Filed 2017·Application pending·0 cites
- 1763US8178109B2Compositions and methods of use for MGD-CSF in disease treatmentBEHRENS DIRK·Filed 2009·Granted May 15, 2012·0 cites·12 claims
- 1863US2006084799A1Human cDNA clones comprising polynucleotides encoding polypeptides and methods of their useWILLIAMS LEWIS T·Filed 2004·Application pending·0 cites
- 1959US11421034B2Combination anti-CSF1R and anti-PD-1 antibody combination therapy for pancreatic cancerFIVE PRIME THERAPEUTICS INC·Filed 2018·Granted Aug 23, 2022·0 cites·15 claims
- 2059US2016096876A1Compositions and methods of treating disease with fgfr fusion proteinsFIVE PRIME THERAPEUTICS INC·Filed 2015·Application pending·0 cites
- 2158US2010015047A1Lung-Expressed PolypeptidesFIVE PRIME THERAPEUTICS INC·Filed 2009·Application pending·0 cites
- 2257US2014170145A1Compositions and methods of use for mgd-csf in disease treatmentFIVE PRIME THERAPEUTICS INC·Filed 2013·Application pending·0 cites
- 2353US10537611B2Methods of treating lung cancerFIVE PRIME THERAPEUTICS INC·Filed 2018·Granted Jan 21, 2020·0 cites·20 claims
- 2453US2010028867A1LRRTM1 Compositions and Methods of Their Use for the Diagnosis and Treatment of CancerBOSCH ELIZABETH·Filed 2006·Application pending·0 cites
- 2552US2007274988A1Kiaa0779, Splice Variants Thereof, and Methods of Their UseFIVE PRIME THERAPEAUTICS INC·Filed 2004·Application pending·0 cites
- 2651US2007264277A1Compositions and Methods of Use for Mgd-Csf in Disease TreatmentBEHRENS DIRK·Filed 2005·Application pending·0 cites
- 2750US10016484B2Methods of treating lung cancerFIVE PRIME THERAPEUTICS INC·Filed 2012·Granted Jul 10, 2018·0 cites·20 claims
- 2850US2007258949A1Human Cdna Clones Comprising Polynucleotides Encoding Polypeptides and Methods of Their UseFIVE PRIME THERAPEUTICS INC·Filed 2005·Application pending·0 cites
- 2949US8404810B2Compositions and methods of use for modulators of polypeptides and polynucleotides in treating breast cancer and melanomaHESTIR KEVIN·Filed 2007·Granted Mar 26, 2013·0 cites·6 claims
- 3047US2007248605A1Fibroblast Growth Factor Receptors 1,2,3, and 4 as Targets for Therapeutic InterventionFIVE PRIME THERAPETUTICS INC·Filed 2004·Application pending·0 cites
- 3146US8058403B2Antibodies to stromal cell-derived factor-1 polypeptidesCHU KETING·Filed 2010·Granted Nov 15, 2011·0 cites·9 claims
- 3242US2008014594A1Lung-Expressed PolypeptidesHESTIR KEVIN·Filed 2004·Application pending·0 cites
- 3341US2009214517A1Compositions and methods of use for modulators of nectin 4, semaphorin 4b, igsf9, and kiaa0152 in treating diseaseWONG JUSTIN·Filed 2005·Application pending·0 cites
- 3439US2008242603A1Novel Apo2L and IL-24 Polypeptides, Polynucleotides, and Methods of Their UseWANG YAN·Filed 2005·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Kevin Hestir files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →